SERUM INSTITUTE OF INDIA
COVID-19 Vaccine Covishield May Get Emergency Use Authorisation From India in December 2020, Says Report
When Will COVID-19 Vaccine Covishield, Developed by Oxford-AstraZeneca, Be Available? Adar Poonawalla Responds
Bharat Biotech, Serum Institute of India Developing Intranasal Vaccines for COVID-19; What Is an Intranasal Vaccine? Updates on Anti-Coronavirus Intranasal Vaccines’ Development
COVID-19 Vaccine: Apollo Hospitals Ready to Administer One Million Coronavirus Vaccines Daily
When Will India Get COVID-19 Vaccine? Here's Where AstraZeneca, Sputnik V And Other Vaccine Trials Stand in India
Forbes India Rich List 2020: Mukesh Ambani Remains Wealthiest Indian For 13th Consecutive Year; Gautam Adani Takes Second Spot; Check List
After Serum Institute Tweet, Union Health Ministry Says ‘It Disagrees With the Mathematics That Rs 80,000 Crore Is Needed to Vaccinate All Indians’
COVID-19 Vaccine Update: Serum Institute of India to Produce Additional 100 Million Doses of Coronavirus Vaccine in 2021
COVID-19 Vaccine Update: Will Modi Govt Have 'Rs 80,000 Crore in Next One Year' to Buy and Distribute Doses? Adar Poonawalla Asks
COVID-19 Vaccine Update: Phase 3 Human Clinical Trial of Oxford Vaccine Covishield Begins in Pune
COVID-19 Vaccine Update: Novavax Inc Extends Pact With Serum Institute, Will Now Produce 200 Crore Coronavirus Vaccine Doses
COVID-19 Vaccine in India Update: Serum Institute to Start Phase 3 Trials of Oxford Candidate After Clearances, Says ICMR
COVID-19 Vaccine: Serum Institute to Resume Trials of Oxford-AstraZeneca Candidate After DCGI Nod
Oxford-AstraZeneca's COVID-19 Vaccine Trials in UK to Resume After Brief Pause Over Volunteer's Illness
DCGI Directs Serum Institute Pune to Suspend Any New Recruitment in Phase 2, 3 COVID-19 Vaccine Clinical Trials
COVID-19 Vaccine Update: Oxford's Coronavirus Vax May Be Ready by Year End In Spite of Pause in Clinical Trials, Says AstraZeneca CEO Pascal Soriot
Google Trends